Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.

Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV.

Health Serv Res. 2009 Oct;44(5 Pt 1):1640-61. doi: 10.1111/j.1475-6773.2009.00989.x. Epub 2009 Jun 3.

2.

Health literacy and antidepressant medication adherence among adults with diabetes: the diabetes study of Northern California (DISTANCE).

Bauer AM, Schillinger D, Parker MM, Katon W, Adler N, Adams AS, Moffet HH, Karter AJ.

J Gen Intern Med. 2013 Sep;28(9):1181-7. doi: 10.1007/s11606-013-2402-8. Epub 2013 Mar 20.

3.

Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE).

Bauer AM, Parker MM, Schillinger D, Katon W, Adler N, Adams AS, Moffet HH, Karter AJ.

J Gen Intern Med. 2014 Aug;29(8):1139-47. doi: 10.1007/s11606-014-2845-6.

4.

Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans.

Despr├ęs F, Forget A, Kettani FZ, Blais L.

J Manag Care Spec Pharm. 2016 May;22(5):539-47. doi: 10.18553/jmcp.2016.22.5.539.

5.

Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.

Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG.

J Manag Care Spec Pharm. 2014 Aug;20(8):851-61.

6.
7.

Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.

Bollinger ME, Diette GB, Chang CL, Stephenson JJ, Sajjan SG, Fan T, Allen-Ramey FC.

Clin Ther. 2010 Jun;32(6):1093-102. doi: 10.1016/j.clinthera.2010.06.003.

PMID:
20637964
8.

Comparing adherence and persistence across 6 chronic medication classes.

Yeaw J, Benner JS, Walt JG, Sian S, Smith DB.

J Manag Care Pharm. 2009 Nov-Dec;15(9):728-40.

9.

Mail-order pharmacy use and adherence to diabetes-related medications.

Duru OK, Schmittdiel JA, Dyer WT, Parker MM, Uratsu CS, Chan J, Karter AJ.

Am J Manag Care. 2010 Jan;16(1):33-40.

10.
11.

Effect of Out-of-Pocket Cost on Medication Initiation, Adherence, and Persistence among Patients with Type 2 Diabetes: The Diabetes Study of Northern California (DISTANCE).

Karter AJ, Parker MM, Solomon MD, Lyles CR, Adams AS, Moffet HH, Reed ME.

Health Serv Res. 2018 Apr;53(2):1227-1247. doi: 10.1111/1475-6773.12700. Epub 2017 May 5.

PMID:
28474736
12.

Store and prescription characteristics associated with primary medication nonadherence.

Jackson TH, Bentley JP, McCaffrey DJ 3rd, Pace P, Holmes E, West-Strum D.

J Manag Care Spec Pharm. 2014 Aug;20(8):824-32.

13.

Impact of Appointment-Based Medication Synchronization on Existing Users of Chronic Medications.

Holdford D, Saxena K.

J Manag Care Spec Pharm. 2015 Aug;21(8):662-9.

14.

Potential bias in medication adherence studies of prevalent users.

Maciejewski ML, Bryson CL, Wang V, Perkins M, Liu CF.

Health Serv Res. 2013 Aug;48(4):1468-86. doi: 10.1111/1475-6773.12043. Epub 2013 Feb 13.

15.

Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada.

Evans CD, Eurich DT, Lamb DA, Taylor JG, Jorgenson DJ, Semchuk WM, Mansell KD, Blackburn DF.

J Manag Care Pharm. 2009 Jul-Aug;15(6):476-84.

16.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

17.

Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.

Spence MM, Makarem AF, Reyes SL, Rosa LL, Nguyen C, Oyekan EA, Kiyohara AT.

J Manag Care Spec Pharm. 2014 Oct;20(10):1036-45.

18.

Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.

Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP.

J Manag Care Pharm. 2009 Jan-Feb;15(1):32-41.

19.
20.

Effects of benefit design change across 5 disease states.

Brixner DI, Joish VN, Odera GM, Avey SG, Hanson DM, Cannon HE.

Am J Manag Care. 2007 Jun;13(6 Pt 2):370-6.

Supplemental Content

Support Center